Transformative immunomodulating medicines for patients 2Q & 1H 2025 Financial Results & Business Update 1 Forward Looking Statements This presentation contains "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words such as "may", "will", "believe", "expect", "plan", "anticipate", "estimate", "continue" and similar expressions (as well as other words or expressions referencing future events or circumstances) are intended to ...

Business Update Steven Basta, President & Chief Executive Officer Q2 2025 Financial Results Robert Breedlove, VP of Finance & Principal Accounting Officer Closing Remarks SECOND QUARTER 2025 EARNINGS CONFERENCE CALL AUGUST 2025 NASDAQ: PHAT Today's Agenda Steven Basta, President & Chief Executive Officer Question & Answer Steven Basta, President & Chief Executive Officer Robert Breedlove, VP of Finance & Principal Accounting Officer 2 Safe harbor This presentation contains forward-looking statements. All st ...

August 7, 2025 SECOND QUARTER 2025 RESULTS DISCLAIMER Forward Looking Statements This presentation contains certain forward-looking statements and information relating to the Company that are based on beliefs of the Company's management as well as assumptions, expectations, projections, intentions and beliefs about future events, in particular regarding dividends (including our dividend plans, timing and the amount and growth of any dividends), daily charter rates, vessel utilization, the future number of n ...

Presentation for Business Update AUGUST 7, 2025 Forward-Looking Statements This communication contains certain forward-looking statements within the meaning of the federal securities laws of the United States. The Company intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 and includes this statement for purposes of complying with these safe harbor provisions. Any statements made ...

Second Quarter and First-Half Performance - Implemented Providers increased by 13.8% compared to the second quarter of 2024[8] - Practice Collections grew by 18.5% compared to the second quarter of 2024[8] - Adjusted EBITDA increased by 31.6%[8] with an Adjusted EBITDA margin of 25.2%, a 310 bps increase compared to the second quarter of 2024[8] - Platform Contribution increased by 15.4% for the second quarter[18] and 15.7% for the six-month period[21] - Care Margin increased by 18.5% for the second quarter[18] and 18.5% for the six-month period[21] Full Year 2025 Guidance - The company raised its full year 2025 guidance to above the high end of the range for Practice Collections, GAAP Revenue, Platform Contribution and Adjusted EBITDA[8] - The company anticipates ending FY'25 with over $450 million in cash, assuming no further capital deployment for business development[25] - The company expects at least 80% of FY'25 Adjusted EBITDA to convert to Free Cash Flow[29] - Initial FY'25 Guidance for Implemented Providers was between 5,200 and 5,300, reaching the high end at 5,300[27] - Initial FY'25 Guidance for Attributed Lives was between 1,300,000 and 1,400,000, reaching the high end at 1,400,000[27]

Financial Performance - DigitalBridge reported GAAP net income attributable to common stockholders of $17 million, or $0.10 per share, in Q2 2025[10, 15] - Fee revenues increased by 8% year-over-year to $854 million in Q2 2025[27, 55, 58] - Fee-Related Earnings (FRE) grew by 23% year-over-year to $32 million in Q2 2025, with a FRE margin of 37%[27, 55, 58, 59] - Distributable Earnings (DE) showed a loss of $186 million in Q2 2025, attributed to a $40 million realized loss from an InfraBridge fund investment[10, 55, 58] - Fee-Earning Equity Under Management (FEEUM) increased by 21% year-over-year to $397 billion as of June 30, 2025[29, 55, 56] Capital Formation and Investment - New capital formation reached $13 billion in Q2 2025, driven by new data center co-invest capital formation, and $25 billion YTD[24, 55] - The company committed $500 million in capital from DigitalBridge and ArcLight for the Takanock data center power infrastructure platform[36] - Capital raised since 2024 to accelerate growth, reduce borrowing costs, and retire acquisition-related debt reached $20 billion[39] Strategic Initiatives and Market Trends - Hyperscaler Capex has increased by 50% from $250 billion to $380 billion[42, 43] - The U S hyperscale data center leasing pipeline is approximately 49 GW[50] - DigitalBridge's data center portfolio has a total secured power of 209 GW, with 54 GW built and under construction[102]

Company Overview and Market Position - Insulet is a global leader in diabetes management with $2.1 billion in 2024 revenue[21] - The company has approximately 500,000 active customers globally[21] - Omnipod is the 1 AID system requested and prescribed in the U S [21] - Omnipod 5 is the first AID system FDA-cleared for both type 1 and type 2 diabetes in the U S [21] Financial Performance and Growth - The company is growing revenue beyond $2.5 billion[24] - The company anticipates approximately 24%-27% constant currency revenue growth for full year 2025[25] - The company is experiencing rapid expansion of adjusted operating margin, with an anticipated expansion of approximately 1,000 bps to reach 17%-17 5%[24, 25] Product Innovation and Clinical Outcomes - Omnipod 5 is the first and only tubeless, waterproof AID in the U S [27] - Omnipod 5 leads to a 20%-23% increase in time in range for adults with type 1 and type 2 diabetes, respectively[27] - Strong SECURE-T2D clinical results show a 0 8% reduction in mean A1c in 13 weeks[29] Market Opportunity and Expansion - The total addressable market is approximately 14 million patients[40] - The company is expanding its market presence outside the U S [50] - The company is building the power of its Omnipod 5 brand globally[57]

Financial Performance - VEON's total revenue reached $1087 million, a 5.9% YoY increase in reported terms and 11.2% in local currency[21, 48] - EBITDA was $520 million, up 13.2% YoY in local currency and 19.6% in reported terms, with an EBITDA margin of 47.8%, a 3.1 percentage point increase[21, 54] - Direct digital revenues grew significantly, reaching $180 million, a 56.6% YoY increase in reported terms and 62.4% in local currency, representing 16.5% of total revenues[21, 48] Digital Growth & Strategy - Direct digital revenues now account for 16.5% of total group revenues, compared to 11.2% in Q2 2024[21] - VEON is focused on growing direct digital revenues through financial services, healthcare, entertainment, ride-hailing, and enterprise services[24] - Multiplay users are driving revenue growth, with multiplay segment revenue reaching $438 million[29, 31] Debt & Liquidity - Net debt (excluding leases) stood at $1962 million, with a net debt to LTM EBITDA ratio of 1.32x[21] - Group cash was $1283 million, including $206 million at the HQ level[21, 58] - The company enhanced financial flexibility with a subsequent $200 million bond placement[16, 58] Revised Outlook - VEON revised its 2025 outlook, projecting total revenue growth of 13%-15% and EBITDA growth of 14%-16% in local currency[15, 60] - Capex intensity is expected to be 17%-19% for 2025[60]

Q2 2025 Financial Performance - Revenue for Q2 2025 was $422 million recurring and $244 million non-recurring[14] - Adjusted EBITDA for Q2 2025 was $95 million, a 20% increase compared to Q2 2024[14] - Diluted EPS for Q2 2025 was $(0.02), while Non-GAAP Diluted EPS was $0.19[14] - Recurring revenue increased by 4% in Q2 2025[14] YTD Q2 2025 Financial Performance - YTD Q2 2025 recurring revenue was $829 million, while non-recurring revenue was $454 million[27] - YTD Q2 2025 Adjusted EBITDA was $170 million, a 20% increase compared to YTD Q2 2024[27] - YTD Q2 2025 Diluted EPS was $(0.19), while Non-GAAP Diluted EPS was $0.27[27] - Recurring revenue increased by 3% YTD Q2 2025[27] FY 2025 Outlook - The company projects total revenue between $2575 million and $2650 million for FY 2025[21] - The company projects adjusted EBITDA between $420 million and $445 million for FY 2025[21] - The company projects non-GAAP diluted EPS between $0.75 and $0.80 for FY 2025[21]

TFG CMD CEO Presentation August 7, 2025 1 Building from a position of strength Mindful of headwinds We're not starting from zero Despite challenges, we're ahead Our strategy is working Our international businesses add strength The team will show you more Much of the heavy lifting is done We'll show you how – with data and realism With diversification, innovation and reach With numbers, plans and proof Today we're going to take it further With the launch of 5 extensions to BOLTS TFG CMD August 2025 2 Althoug ...